Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 12784223

Screening methods: current status.

Deborah Hayes
View original source ↗Export metadata ↓

Abstract

Two technologies are currently used to screen newborn infants for hearing, auditory brainstem response (ABR), and otoacoustic emissions (OAEs). Each technology is based on detecting the infant's physiologic response to auditory stimulation. ABR is a short-latency auditory evoked response originating from eighth nerve and brainstem auditory pathway structures and detected by scalp surface electrodes. OAEs are auditory signals generated by cochlear outer hair cells in response to acoustic stimulation and detected by a miniature microphone coupled to the infant's ear. Although each technique requires specific sound generation and response recording technologies, advances in computerized stimulus delivery and response detection algorithms allow these tests to be performed by trained technicians or volunteers under the supervision of an audiologist. Results of test performance, and the advantages and disadvantages of each technique are described.

Explore related subjects

Evoked Potentials, AuditoryEvoked Potentials, Auditory, Brain StemHearing LossHearing TestsHistory, 20th CenturyHumansInfant, NewbornNeonatal ScreeningOtoacoustic Emissions, SpontaneousEditorialHistorical ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.Review

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Deborah Hayes. 2003. Screening methods: current status.. https://doi.org/10.1002/mrdd.10061

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Short-term serial magnetoencephalography recordings offetal auditory evoked responses.

The study objective was to determine whether short-term serial magnetoencephalographic (MEG) measurements would increase the odds in favor of obtaining fetal auditory evoked responses in normal fetuses. The recordings were performed in two phases using the newly developed 151-channel fetal MEG system, superconducting quantum interference device array for reproductive assessment. Ten pregnant subjects with gestational ages ranging from 30-35 weeks were recruited to participate. Daily recordings were performed over a minimum of 3 days during 1 week of gestation and repeated in the same subjects between 36 and 40 weeks gestation. In 80% of subjects, auditory evoked responses were detected at least once. In healthy fetuses, serial recordings over a short span of time increased the rate of detecting fetal evoked response.

Evoked Potentials, Auditory↗
PubMed2002

Newborn hearing screening in Western Australia.

AIM: To report the preliminary findings of a pilot program to screen newborn babies for congenital bilateral permanent hearing loss. SETTING: The five largest maternity hospitals in Perth, Western Australia. Screening was gradually introduced over seven months from February to August 2000. PARTICIPANTS: All babies born at these hospitals after the introduction of hearing screening until 30 June 2001. METHODS: One or both of two automated screening devices were used: one measuring transient evoked otoacoustic emissions (TEOAE) and the other automated auditory brainstem responses (AABR). If a "pass" was not obtained in both ears, screening was repeated. All babies who did not obtain a pass in either ear at follow-up were referred for audiological assessment. MAIN OUTCOME MEASURES: Prevalence of permanent bilateral hearing loss. RESULTS: Of 13 214 eligible babies, 12 708 (96.2%) received screening. The main reason for missing screening was early hospital discharge (309; 2.3%). Of the screened babies, 99% had a pass response in both ears at either the initial or follow-up screen. Twenty-three babies were referred for audiological assessment, and nine were diagnosed with bilateral permanent hearing loss (0.68/1000; 95% CI, 0.31-1.28). CONCLUSIONS: Despite our program meeting process quality indicators, our detection rate was low. Before extending the program to smaller hospitals, we need to validate our screening instruments and put in place a system to monitor false negative results.

Evoked Potentials, Auditory↗
PubMed2002

Application of an MEG eigenspace beamformer to reconstructing spatio-temporal activities of neural sources.

We have applied the eigenspace-based beamformer to reconstruct spatio-temporal activities of neural sources from MEG data. The weight vector of the eigenspace-based beamformer is obtained by projecting the weight vector of the minimum-variance beamformer onto the signal subspace of a measurement covariance matrix. This projection removes the residual noise-subspace component that considerably degrades the signal-to-noise ratio (SNR) of the beamformer output when errors in estimating the sensor lead field exist. Therefore, the eigenspace-based beamformer produces a SNR considerably higher than that of the minimum-variance beamformer in practical situations. The effectiveness of the eigenspace-based beamformer was validated in our numerical experiments and experiments using auditory responses. We further extended the eigenspace-based beamformer so that it incorporates the information regarding the noise covariance matrix. Such a prewhitened eigenspace beamformer was experimentally demonstrated to be useful when large background activity exists.

Evoked Potentials, Auditory↗